Atai Life Sciences Other Non-Current Liabilities 2020-2024 | ATAI
Atai Life Sciences other non-current liabilities from 2020 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Atai Life Sciences Annual Other Non-Current Liabilities
(Millions of US $) |
| 2023 |
$10 |
| 2022 |
$5 |
| 2021 |
$7 |
| 2020 |
$2 |
| 2019 |
$1 |
Atai Life Sciences Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-06-30 |
$10 |
| 2024-03-31 |
$10 |
| 2023-12-31 |
$10 |
| 2023-09-30 |
$4 |
| 2023-06-30 |
$4 |
| 2023-03-31 |
$4 |
| 2022-12-31 |
$5 |
| 2022-09-30 |
$6 |
| 2022-06-30 |
$6 |
| 2022-03-31 |
$5 |
| 2021-12-31 |
$7 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.265B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
